PMC:6640909 / 75120-75477 JSONTXT

{"project":"TEST0","denotations":[{"id":"31100109-132-138-7591","span":{"begin":132,"end":134},"obj":"[\"27955912\"]"},{"id":"31100109-140-147-7592","span":{"begin":140,"end":143},"obj":"[\"27573150\"]"},{"id":"31100109-206-213-7593","span":{"begin":352,"end":355},"obj":"[\"29157741\"]"}],"text":"Implantable BiVAD (e.g. 2 CF-LVADs) support might be considered in patients at high risk of RV failure having bridge to transplant [81, 187–191].\nOff-label use of implantable axial-flow or centrifugal LVADs has been adopted as RVAD support in conjunction with implantable LVAD support as an alternative to extracorporeal BiVAD or TAH implantation [192–196]."}

{"project":"MyTest","denotations":[{"id":"31100109-27955912-28905651","span":{"begin":132,"end":134},"obj":"27955912"},{"id":"31100109-27573150-28905652","span":{"begin":140,"end":143},"obj":"27573150"},{"id":"31100109-29157741-28905653","span":{"begin":352,"end":355},"obj":"29157741"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Implantable BiVAD (e.g. 2 CF-LVADs) support might be considered in patients at high risk of RV failure having bridge to transplant [81, 187–191].\nOff-label use of implantable axial-flow or centrifugal LVADs has been adopted as RVAD support in conjunction with implantable LVAD support as an alternative to extracorporeal BiVAD or TAH implantation [192–196]."}

{"project":"0_colil","denotations":[{"id":"31100109-27955912-7591","span":{"begin":132,"end":134},"obj":"27955912"},{"id":"31100109-27573150-7592","span":{"begin":140,"end":143},"obj":"27573150"},{"id":"31100109-29157741-7593","span":{"begin":352,"end":355},"obj":"29157741"}],"text":"Implantable BiVAD (e.g. 2 CF-LVADs) support might be considered in patients at high risk of RV failure having bridge to transplant [81, 187–191].\nOff-label use of implantable axial-flow or centrifugal LVADs has been adopted as RVAD support in conjunction with implantable LVAD support as an alternative to extracorporeal BiVAD or TAH implantation [192–196]."}

{"project":"2_test","denotations":[{"id":"31100109-27955912-28905651","span":{"begin":132,"end":134},"obj":"27955912"},{"id":"31100109-27573150-28905652","span":{"begin":140,"end":143},"obj":"27573150"},{"id":"31100109-29157741-28905653","span":{"begin":352,"end":355},"obj":"29157741"}],"text":"Implantable BiVAD (e.g. 2 CF-LVADs) support might be considered in patients at high risk of RV failure having bridge to transplant [81, 187–191].\nOff-label use of implantable axial-flow or centrifugal LVADs has been adopted as RVAD support in conjunction with implantable LVAD support as an alternative to extracorporeal BiVAD or TAH implantation [192–196]."}